Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Cancers|October 14, 2023
Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal CancerJosefine Schardey, Can Lu, Jens Neumann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2016
Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosisAriane Aigelsreiter, Jens Neumann, Martin Pichler, et al.
Surgery|March 31, 2015
Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of VaterTobias S Schiergens, Simone Reu, Jens Neumann, et al.
Cancer Research|October 11, 2022
SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and MetastasisLeon P Loevenich, Markus Tschurtschenthaler, Matjaz Rokavec, et al.
Radiation Oncology (London, England)|January 4, 2020
Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapyKathrin Gennen, Lukas Käsmann, Julian Taugner, et al.
Anticancer Research|March 28, 2023
Treatment of Mediastinal Endometrial Carcinoma Developed from Extragenital Endometriosis and Simultaneous Rectal Adenocarcinoma in a 55-year-old WomanKlara Dorman, Danmei Zhang, Wolfgang G Kunz, et al.
Molecular and Cellular Endocrinology|September 21, 2016
Loss of DRO1/CCDC80 results in obesity and promotes adipocyte differentiationJessica I Grill, Jens Neumann, Andreas Herbst, et al.
International Journal of Cancer|May 31, 2012
Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study GroupSebastian Stintzing, Christine Kapaun, Rüdiger Paul Laubender, et al.
Journal of Gastroenterology|February 26, 2013
KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancerStefan Boeck, Andreas Jung, Rüdiger P Laubender, et al.
Journal of Cancer Research and Clinical Oncology|July 4, 2023
Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practiceJulia Walter, Caroline Moeller, Blerina Resuli, et al.
Pageof 15